生产与市场：合理解决卡介苗短缺问题。
Manufacturing and the Market: Rationalizing the Shortage of Bacillus Calmette-Guérin.
机构信息
Department of Urology, University of Pittsburgh School of Medicine, Pittsburgh, PA, USA.
Department of Urology, University of Pittsburgh School of Medicine, Pittsburgh, PA, USA.
出版信息
Eur Urol Focus. 2018 Jul;4(4):481-484. doi: 10.1016/j.euf.2018.06.018. Epub 2018 Jul 11.
PMID:30005997
Abstract
Bacillus Calmette-Guérin (BCG) is used as first-line intravesical therapy following tumor resection of non-muscle-invasive bladder cancer. Primary producers of BCG announced shortages within the last decade, leading to a worldwide shortage. We review the literature examining the BCG shortage and propose solutions to cope with this problem.
摘要
卡介苗（BCG）用于非肌肉浸润性膀胱癌肿瘤切除后的一线膀胱内治疗。BCG 的主要生产商在过去十年内宣布短缺，导致全球范围内短缺。我们回顾了研究 BCG 短缺的文献，并提出了解决这一问题的方法。
Zotero 插件